• Univercell-Biosolutions launches center of expertise with industrial and standardized approach to hiPSc cell line production


    The center of expertise offers quality control and process management applied to a large panel of standardized products based on the Pluri-one® platform » Read more

  • Acquisition of iPS Cell Patent license from iPS Academia Japan


    Non-exclusive worldwide licence will enable Univercell-Biosolutions to produce human cardiomyocytes for efficacy and toxicology testing » Read more